Venn Life Sciences

Contract research company Open Orphan said its subsidiary hVivo has signed a deal with a major pharmaceutical client to manufacture a virus for use in(...)

Venn Life Sciences, a subsidiary of Irish based Open Orphan, has been awarded two new contracts, including a Covid-19 drug trial. Open Orphan is a s(...)

Dublin-listed pharmaceutical services company Open Orphan has agreed a new two year contract with one of Europe’s top research-driven pharmaceutical c(...)

Dublin-listed pharmaceutical services company Open Orphan says it expects to hit profitability in the fourth quarter. The company has been aggressive(...)

Dublin-listed pharmaceutical services company Open Orphan has secured a long-term contract to support a major European pharmaceutical company. The co(...)

Dublin-listed pharmaceutical services company Open Orphan has signed a new deal with New York-based Codagenix for the phase one trial of a new Covid-1(...)

Dublin-listed pharmaceutical services company Open Orphan has signed an option to acquire a company which supports drug trials “for a nominal sum”. (...)

Dublin-listed pharmaceutical services company Open Orphan said it has developed the world’s first challenge study model to test the efficacy of the la(...)

Dublin-listed pharmaceutical services company Open Orphan has signed a deal with an unnamed vaccine developer through its Venn Life Sciences unit. T(...)

Dublin-listed pharmaceutical services company Open Orphan has launched its Covid-19 antibody testing service, supporting the reopening of economies as(...)